Sandbox/table: Difference between revisions

Jump to navigation Jump to search
Guillermo Rodriguez Nava (talk | contribs)
Guillermo Rodriguez Nava (talk | contribs)
Line 14: Line 14:
==table==
==table==


{| style="border: 2px solid #DCDCDC; font-size: 90%; width: 30%;"
{| style="border: 2px solid #DCDCDC; font-size: 90%; width: 100%;"
|+ '''Ebola virus strains identified'''
|+ '''Differential Diagnosis of Measles'''
|-
|-
! style="width: 100px; background: #4479BA; text-align: center;"|{{fontcolor|#FFF|Ebola virus strain}}
! style="width: 200px; background: #4479BA; text-align: center;"|{{fontcolor|#FFF|Disease}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Place of discovery}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Agent}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Date}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Typical Season}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Typical Age}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Prodrome}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Fever}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Duration of the rash (days)}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Rash}}
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Other Signs & Symptoms}}
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Sudan ebolavirus'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Measles'''
| style="background: #DCDCDC; padding: 5px;"| Sudan
| style="background: #DCDCDC; padding: 5px;"| Paramyxovirus<br>Measles virus
| style="background: #F5F5F5; padding: 5px;"| Between June and November 1976
| style="background: #F5F5F5; padding: 5px;"| Winter - Spring
| style="background: #DCDCDC; padding: 5px;"| 1 to 20 years
| style="background: #F5F5F5; padding: 5px;"| 2-4 days of cough, conjuctivitis, and coryza
| style="background: #DCDCDC; padding: 5px;"| High
| style="background: #F5F5F5; padding: 5px;"| 5 - 6
| style="background: #DCDCDC; padding: 5px;"| Erythematous, irregular size, maculopapular; starts on temples & behind ears; progresses down from face; fades to brownish
| style="background: #F5F5F5; padding: 5px;"| Koplik’s spots: C blue-white papules (salt grains) on bright red mucosa opposite premolar teeth
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Zaire ebolavirus'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Kawasaki disease'''
| style="background: #DCDCDC; padding: 5px;"| Yambuku, Democratic Republic of the Congo (formerly Zaire)
| style="background: #DCDCDC; padding: 5px;"| Unknown
| style="background: #F5F5F5; padding: 5px;"| Between August and November 1976
| style="background: #F5F5F5; padding: 5px;"| Winter - Spring
| style="background: #DCDCDC; padding: 5px;"| < 5 years
| style="background: #F5F5F5; padding: 5px;"| 3 days of abrupt fever
| style="background: #DCDCDC; padding: 5px;"| High; fever of 5 days is a diagnostic criteria
| style="background: #F5F5F5; padding: 5px;"| 5 - 7
| style="background: #DCDCDC; padding: 5px;"| Erythematous, morbilliform, maculopapular or scarlatiniform, central distribution; erythematous, indurated palms and soles
| style="background: #F5F5F5; padding: 5px;"| Acute: dry, fissured and injected lips, strawberry tongue; irritability; cervical lymphadenopathy; conjunctival injection; peripheral edema Subacute: finger-tip desquamation; Complications: arthritis, carditis
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Reston ebolavirus'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Roseola Infantum (exanthem subitum)'''
| style="background: #DCDCDC; padding: 5px;"| Reston, Virginia, US.
| style="background: #DCDCDC; padding: 5px;"| Human herpes virus type 6
 
| style="background: #F5F5F5; padding: 5px;"| Any season
| style="background: #F5F5F5; padding: 5px;"| November 1989
| style="background: #DCDCDC; padding: 5px;"| 6 months to 2 years
| style="background: #F5F5F5; padding: 5px;"| None
| style="background: #DCDCDC; padding: 5px;"| High
| style="background: #F5F5F5; padding: 5px;"| 1-2; it follows defervescence
| style="background: #DCDCDC; padding: 5px;"| Discrete erythematous macules, rarely involves face, begins as fever ends
| style="background: #F5F5F5; padding: 5px;"| Lymphadenopathy, irritability
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Ivory Coast ebolavirus'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Ivory Coast ebolavirus'''
| style="background: #DCDCDC; padding: 5px;"| Tai Forest, Cote d'Ivoire.
| style="background: #DCDCDC; padding: 5px;"|  
 
| style="background: #F5F5F5; padding: 5px;"|
| style="background: #F5F5F5; padding: 5px;"| November 1994
| style="background: #DCDCDC; padding: 5px;"|
| style="background: #F5F5F5; padding: 5px;"|
| style="background: #DCDCDC; padding: 5px;"|
| style="background: #F5F5F5; padding: 5px;"|
| style="background: #DCDCDC; padding: 5px;"|
| style="background: #F5F5F5; padding: 5px;"|
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Bundibugyo ebolavirus'''
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Bundibugyo ebolavirus'''
| style="background: #DCDCDC; padding: 5px;"| Bundibugyo District, Uganda
| style="background: #DCDCDC; padding: 5px;"|  
 
| style="background: #F5F5F5; padding: 5px;"|
| style="background: #F5F5F5; padding: 5px;"| November 2007
| style="background: #DCDCDC; padding: 5px;"|
| style="background: #F5F5F5; padding: 5px;"|
| style="background: #DCDCDC; padding: 5px;"|
| style="background: #F5F5F5; padding: 5px;"|
| style="background: #DCDCDC; padding: 5px;"|
| style="background: #F5F5F5; padding: 5px;"|
|}
|}



Revision as of 16:38, 24 June 2014

The following table contains the main risk factors for CDI:[1][2][3][2][2]

Alterations in the coagulation system
Consumption of clotting factors
Increased concentrations of fibrin degradation products
Disseminated intravascular coagulation

table

Differential Diagnosis of Measles
Disease Agent Typical Season Typical Age Prodrome Fever Duration of the rash (days) Rash Other Signs & Symptoms
Measles Paramyxovirus
Measles virus
Winter - Spring 1 to 20 years 2-4 days of cough, conjuctivitis, and coryza High 5 - 6 Erythematous, irregular size, maculopapular; starts on temples & behind ears; progresses down from face; fades to brownish Koplik’s spots: C blue-white papules (salt grains) on bright red mucosa opposite premolar teeth
Kawasaki disease Unknown Winter - Spring < 5 years 3 days of abrupt fever High; fever of 5 days is a diagnostic criteria 5 - 7 Erythematous, morbilliform, maculopapular or scarlatiniform, central distribution; erythematous, indurated palms and soles Acute: dry, fissured and injected lips, strawberry tongue; irritability; cervical lymphadenopathy; conjunctival injection; peripheral edema Subacute: finger-tip desquamation; Complications: arthritis, carditis
Roseola Infantum (exanthem subitum) Human herpes virus type 6 Any season 6 months to 2 years None High 1-2; it follows defervescence Discrete erythematous macules, rarely involves face, begins as fever ends Lymphadenopathy, irritability
Ivory Coast ebolavirus
Bundibugyo ebolavirus

table

Countries with a reported prevalence <15% of H. pylori resistance to clarithromycin
Diagnostic test North America South America Middle East Far East
ELISA (serology) detects:
  • Viral Antigen
  • IgM and IgG antibody | hol

There is a reported prevalence of 15% in the Northeast of the US.

  1. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012). "Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics". J Antimicrob Chemother. 67 (3): 742–8. doi:10.1093/jac/dkr508. PMID 22146873.
  2. 2.0 2.1 2.2 Knight, Christopher L.; Surawicz, Christina M. (2013). "Clostridium difficile Infection". Medical Clinics of North America. 97 (4): 523–536. doi:10.1016/j.mcna.2013.02.003. ISSN 0025-7125.
  3. Planche, Tim (2013). "Clostridium difficile". Medicine. 41 (11): 654–657. doi:10.1016/j.mpmed.2013.08.003. ISSN 1357-3039.